Trends in antibiotic resistance patterns and burden of Escherichia coli infections in young children: a retrospective cross-sectional study in Shenzhen, China from …

S Patil, H Chen, Y Chen, S Dong, H Mai… - Infection and Drug …, 2023 - Taylor & Francis
Purpose The emergence of multi-drug resistant ESBL-producing E. coli poses a global
health problem. In this study, we aimed to investigate the prevalence of E. coli infections and …

Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and …

CC Lin, JY Wu, PY Huang, HL Sung… - Expert Review of Anti …, 2024 - Taylor & Francis
Introduction Our objective is to determine whether prolonged infusion (PI) of beta-lactam
antibiotics yields superior outcomes compared to intermittent infusion (II) in patients with …

Knowledge, attitude, and practices of mothers working as nurses toward multidrug-resistant: impact of an educational program in neonatal intensive care unit

S Abuhammad, D Alwedyan, S Hamaideh… - Infection and Drug …, 2024 - Taylor & Francis
Objective This study seeks to assess the influence of an educational program on enhancing
the knowledge, attitudes, and practices of NICU nurses regarding MDROs. Methodology …

A Pharmacovigilance Study of adverse events associated with polymyxins based on the US Food and Drug Administration adverse event reporting system (FAERS) …

T Wu, Y Shi, C Xu, B Zhu, D Li, Z Li… - Expert Opinion on …, 2024 - Taylor & Francis
Background Polymyxins have been regarded as last-line treatment for multidrug-resistant
gram-negative bacterial infections. Nonetheless, concerns regarding toxicity persist. This …

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to …

T Shi, L Xie - Frontiers in Microbiology, 2023 - frontiersin.org
Background Gram-negative bacilli are one of the most common causes of various infections
in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli …

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection

Z Zheng, Z Shao, L Lu, S Tang, K Shi, F Gong… - BMC Infectious …, 2023 - Springer
Background The rapid global emergence and spread of carbapenem-resistant Gram-
negative bacilli (CR-GNB) is recognized as a major public health concern, and there are …

Risk predict model using multi-drug resistant organism infection from Neuro-ICU patients: a retrospective cohort study

H Jiang, H Pu, N Huang - Scientific Reports, 2023 - nature.com
The aim of this study was to analyze the current situation and risk factors of multi-drug-
resistant organism (MDRO) infection in Neuro-intensive care unit (ICU) patients, and to …

Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective …

J Xu, X Du, D Li, P Li, Q Guo, X Xu, F Hu… - BMC Infectious …, 2024 - Springer
Abstract Objective Healthcare-associated Gram-negative bacterial meningitis is a
substantial clinical issue with poor outcomes, especially for neurosurgical patients. Here, we …

Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from …

DT Dao, HY Le, MH Nguyen, TD Thi, XD Nguyen… - BMC Infectious …, 2024 - Springer
Background Respiratory infections have long been recognized as a primary cause of acute
exacerbation of chronic obstructive pulmonary disease (AE-COPD). Additionally, the …

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate

W Li, Y Liu, L Xiao, X Cai, W Gao, D Xu… - Frontiers in …, 2024 - frontiersin.org
Background Carbapenem-resistant Gram-negative organism (CRO) infection is a critical
clinical disease with high mortality rates. The 30-day mortality rate following antibiotic …